Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Boberg

Showing results (441-450 of 619) with videos related to

Pageof 62
Sort By:
Psychosomatic Medicine|June 26, 2023
Virtual Human-Delivered Interviews for Patients With Chronic Pain: Feasibility, Acceptability, and a Pilot Randomized Trial of Standard Medical, Psychosocial, and Educational InterviewsDoerte U Junghaenel, Stefan Schneider, Gale Lucas, et al.
European Journal of Clinical Investigation|February 15, 2019
Cholangiocarcinoma is associated with a raised enhanced liver fibrosis score independent of primary sclerosing cholangitisFrancesca Saffioti, Davide Roccarina, Mette Vesterhus, et al.
British Journal of Clinical Pharmacology|December 1, 1984
Initial clinical experience with ICI 141,292 (Visacor), a new selective beta 1-adrenoceptor blocker with ISA--a multicentre trial in 59 patientsB Dahlöf, M Danielson, O Andersson, et al.
The American Journal of Gastroenterology|November 15, 2006
Genetic polymorphisms associated with inflammatory bowel disease do not confer risk for primary sclerosing cholangitisTom H Karlsen, Jochen Hampe, Kristine Wiencke, et al.
Patient Education and Counseling|March 19, 2003
Assessing the unmet information, support and care delivery needs of men with prostate cancerEric W Boberg, David H Gustafson, Robert P Hawkins, et al.
Genes and Immunity|February 16, 2007
Different HLA class II associations in ulcerative colitis patients with and without primary sclerosing cholangitisT H Karlsen, K M Boberg, M Vatn, et al.
Scandinavian Journal of Gastroenterology|January 6, 2018
Risk factors and prognosis for recurrent primary sclerosing cholangitis after liver transplantation: a Nordic Multicentre StudyLina Lindström, Kristin K Jørgensen, Kirsten M Boberg, et al.
Gut|July 17, 2001
Association of the tumour necrosis factor alpha -308 but not the interleukin 10 -627 promoter polymorphism with genetic susceptibility to primary sclerosing cholangitisS A Mitchell, J Grove, A Spurkland, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|July 17, 2010
Cytochrome P4501A1 is required for vascular dysfunction and hypertension induced by 2,3,7,8-tetrachlorodibenzo-p-dioxinPhillip G Kopf, Jason A Scott, Larry N Agbor, et al.
Carcinogenesis|May 16, 2009
Catalytically impaired hMYH and NEIL1 mutant proteins identified in patients with primary sclerosing cholangitis and cholangiocarcinomaMonika Forsbring, Erik S Vik, Bjørn Dalhus, et al.
Pageof 62

Showing results (441-450 of 619) with videos related to

Sort By:
Pageof 62
Psychosomatic Medicine|June 26, 2023
Virtual Human-Delivered Interviews for Patients With Chronic Pain: Feasibility, Acceptability, and a Pilot Randomized Trial of Standard Medical, Psychosocial, and Educational InterviewsDoerte U Junghaenel, Stefan Schneider, Gale Lucas, et al.
European Journal of Clinical Investigation|February 15, 2019
Cholangiocarcinoma is associated with a raised enhanced liver fibrosis score independent of primary sclerosing cholangitisFrancesca Saffioti, Davide Roccarina, Mette Vesterhus, et al.
British Journal of Clinical Pharmacology|December 1, 1984
Initial clinical experience with ICI 141,292 (Visacor), a new selective beta 1-adrenoceptor blocker with ISA--a multicentre trial in 59 patientsB Dahlöf, M Danielson, O Andersson, et al.
The American Journal of Gastroenterology|November 15, 2006
Genetic polymorphisms associated with inflammatory bowel disease do not confer risk for primary sclerosing cholangitisTom H Karlsen, Jochen Hampe, Kristine Wiencke, et al.
Patient Education and Counseling|March 19, 2003
Assessing the unmet information, support and care delivery needs of men with prostate cancerEric W Boberg, David H Gustafson, Robert P Hawkins, et al.
Genes and Immunity|February 16, 2007
Different HLA class II associations in ulcerative colitis patients with and without primary sclerosing cholangitisT H Karlsen, K M Boberg, M Vatn, et al.
Scandinavian Journal of Gastroenterology|January 6, 2018
Risk factors and prognosis for recurrent primary sclerosing cholangitis after liver transplantation: a Nordic Multicentre StudyLina Lindström, Kristin K Jørgensen, Kirsten M Boberg, et al.
Gut|July 17, 2001
Association of the tumour necrosis factor alpha -308 but not the interleukin 10 -627 promoter polymorphism with genetic susceptibility to primary sclerosing cholangitisS A Mitchell, J Grove, A Spurkland, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|July 17, 2010
Cytochrome P4501A1 is required for vascular dysfunction and hypertension induced by 2,3,7,8-tetrachlorodibenzo-p-dioxinPhillip G Kopf, Jason A Scott, Larry N Agbor, et al.
Carcinogenesis|May 16, 2009
Catalytically impaired hMYH and NEIL1 mutant proteins identified in patients with primary sclerosing cholangitis and cholangiocarcinomaMonika Forsbring, Erik S Vik, Bjørn Dalhus, et al.
Pageof 62